β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity-Reference-Cited by-同舟云学术

β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity

Published:1995-05 Issue:4 Volume:81 Page:525-531
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Zheng Hui,Jiang Minghao,Trumbauer Myrna E.,Sirinathsinghji Dalip J.S.,Hopkins Ruth,Smith David W.,Heavens Robert P.,Dawson Gerard R.,Boyce Susan,Conner Michael W.,Stevens Karla A.,Slunt Hilda H.,Sisodia Sangram S.,Chen Howard Y.,Van der Ploeg Lex H.T.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference51 articles.

1. Production and analysis of chimeric mice;Bradley,1987

2. Release of excess amyloid β protein from a mutant amyloid β protein precursor;Cai;Science,1993

3. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production;Citron;Nature,1992

4. apl-1, a Caenorhabditis elegans gene encoding a protein related to the human β-amyloid protein precursor;Daigle,1993

5. Molecular profile of reactive astrocytes: implications for their role in neurologic disease;Eddleston;Neuroscience,1993

Cited by 597 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reciprocal relationship between amyloid precursor protein and mitochondrial function;Journal of Neurochemistry;2024-07-18

2. A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease;Alzheimer's Research & Therapy;2024-07-05

3. Amyloid precursor protein induces reactive astrogliosis;Acta Physiologica;2024-04-08

4. Conclusive demonstration of iatrogenic Alzheimer’s disease transmission in a model of stem cell transplantation;Stem Cell Reports;2024-04

5. A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer’s Disease;2024-03-22